Skip NavigationSkip to Content
Return Return to Search Results

Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy

  1. Author:
    Hai, M.
    Adler, R.
    Bauer, T. R.
    Tuschong, L. M.
    Gu, Y. C.
    Wu, X.
    Hickstein, D. D.

  2. Author Address

    Hai, M.; Adler, R. L.; Bauer, T. R., Jr.; Tuschong, L. M.; Gu, Y-C, Hickstein, D. D.] NCI, Expt Transplantat & Immunol Res, Ctr Canc Res, NIH, Bethesda, MD 20892 USA. [Wu, X.] Natl Canc Inst Frederick, Lab Mol Technol, Sci Applicat Int Corp Frederick, Frederick, MD USA.
    1. Year: 2008
  2. Journal: Gene Therapy
    1. 15
    2. 14
    3. Pages: 1067-1071
  4. Type of Article: Proceedings Paper
  1. Abstract:

    Integration site analysis was performed on six dogs with canine leukocyte adhesion deficiency ( CLAD) that survived greater than 1 year after infusion of autologous CD34+ bone marrow cells transduced with a gammaretroviral vector expressing canine CD18. A total of 387 retroviral insertion sites (RIS) were identified in the peripheral blood leukocytes from the six dogs at 1 year postinfusion. A total of 129 RIS were identified in CD3+ T-lymphocytes and 102 RIS in neutrophils from two dogs at 3 years postinfusion. RIS occurred preferentially within 30 kb of transcription start sites, including 40 near oncogenes and 52 near genes active in hematopoietic stem cells. Integrations clustered around common insertion sites more frequently than random. Despite potential genotoxicity from RIS, to date there has been no progression to oligoclonal hematopoiesis and no evidence that vector integration sites influenced cell survival or proliferation. Continued follow-up in disease-specific animal models such as CLAD will be required to provide an accurate estimate of the genotoxicity using gammaretroviral vectors for hematopoietic stem cell gene therapy.

    See More

  1. Keywords:

External Sources

  1. PMID: 18369320

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel